Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7c6f35eb968c4fb96f0f0b8fa6b4ddc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N7-00 |
filingDate |
2019-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ed0fbd26b74c35f293b88df2232bef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217cc63d80c7456ce0609ab067df3c94 |
publicationDate |
2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112020013915-A2 |
titleOfInvention |
dosing regimen for release, and, method to treat cancer dependent on cdk4 / 6 replication in a human |
abstract |
a human oral dosing regimen of g1t38 that provides a ratio (mean auc (0-24), ss (h * ng / ml)) / (dose (mg)) less than 5 and / or a ratio (mean auc (0 -24), ss (h * ng / ml)) / (absolute neutrophil count (cells / mm3)) on day 22 of termination not exceeding 1.25. |
priorityDate |
2018-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |